South Korea's Penetrium Bioscience said Wednesday that the company would start a clinical test combining its investigational cancer drug Penetrium with Merck's immunotherapy Keytruda. Penetrium Bioscience tests new combination cancer treatment with Merck’s Keytruda
4 months ago
45
South Korea's Penetrium Bioscience said Wednesday that the company would start a clinical test combining its investigational cancer drug Penetrium with Merck's immunotherapy Keytruda. 
English (US) ·